Clinical Trials Directory

Trials / Completed

CompletedNCT01038102

Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance

Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance: a Randomized Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Uppsala University · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate whether substituting saturated fats with polyunsaturated fats reduces fatty liver and improves insulin action and other metabolic variables in abdominally obese subjects

Detailed description

Specific goals: 1. Investigate if substituting saturated fats with polyunsaturated fats reduces steatosis and improves hepatic and/or peripheral insulin action in abdominally obese subjects with type 2 diabetes 2. Investigate if changes of lipogenic enzymes in response to dietary fat intervention are associated with changes in hepatic/peripheral insulin sensitivity or liver fat content 3. Investigate potential mechanism of the effects of dietary fatty acids; e.g. gene expression and lipogenic enzyme activity

Conditions

Interventions

TypeNameDescription
OTHERPUFA DietDiet high in polyunsaturated (rich in linoleic acid, omega-6) fat (15 E%).
OTHERSFA dietDiet high in saturated fat (15E%)

Timeline

Start date
2009-02-01
Primary completion
2010-04-01
Completion
2010-04-01
First posted
2009-12-23
Last updated
2010-07-13

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01038102. Inclusion in this directory is not an endorsement.